Addition of K22 Converts Spider Venom Peptide Pme2a from an Activator to an Inhibitor of NaV1.7
Kathleen Yin(The University of Queensland), Irina Vetter(Centre National de la Recherche Scientifique), Aihua Jin(The University of Queensland), Zoltan Dekan(The University of Queensland), Paul F. Alewood(The University of Queensland), Volker Herzig(University of Tübingen), Jennifer R. Deuis(The University of Queensland), Glenn F. King(The University of Queensland)
Cited by 9
Related Papers
A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
|Nature Medicine|2015|2.8k
Methods Used to Evaluate Pain Behaviors in Rodents
|Frontiers in Molecular Neuroscience|2017|1.3k
Pathophysiology of Chemotherapy-Induced Peripheral Neuropathy
|Frontiers in Molecular Neuroscience|2017|654
Conus Venom Peptide Pharmacology
|Pharmacological Reviews|2012|422
ConoServer: updated content, knowledge, and discovery tools in the conopeptide database
|Nucleic Acids Research|2011|374